ImmunoGen (IMGN) Earns $2M Milestone Payment

Social
Share

0 (0 Likes / 0 Dislikes)

Embed Video
Embed normal player Copy to Clipboard
Embed a smaller player Copy to Clipboard
Advanced Embedding Options
Embedding Options

Size:

Language:

Embed Code

Copy to Clipboard
Invite a user to Dotsub

Your invitation to join Dotsub was successful

There was an error inviting that user to Dotsub

Video Details

Duration: 1 minute and 54 seconds

Country: United States

Language: English

License: CC - Attribution No Derivatives

Genre: News Broadcast

Posted by: karmastock on Jun 15, 2011

ImmunoGen (IMGN) recently reported that Bayer HealthCare Pharmaceuticals’ submission of an Investigational New Drug application for the TAP compound, BAY 94-9343, triggers a $2 million milestone payment to ImmunoGen—

Report this video as offensive

ImmunoGen (IMGN) Earns $2M Milestone Payment

Embed Video

Video Details

Caption and Translate

Other videos from karmastock

CRWENewswire CEO Interviews: Alan Stone & Company, LLC

(DAVE, CRWE, ROYL) CRWENewswire Stocks to Watch